OWNERSHIPNew York

Rise rebrands to Fiorello Pharmaceuticals in New York license restructuring

Rise changes operating name to Fiorello Pharmaceuticals, Inc. on NY license roster amid broader wave of ownership and entity name changes.

The Cannabis Newz Automated Desk

Machine-written from our data · source: State license roster

August 28, 2026 · 9:38 AM ET

Business handshake in an office — file photo, not the scene of this story.

Rise has undergone a licensee name change to Fiorello Pharmaceuticals, Inc. according to New York's state license roster updated August 28. The change appears as part of a broader corporate restructuring activity across the state's cannabis market, with multiple operators simultaneously updating legal entity names.

The rebranding coincides with a surge in ownership changes filed across New York in late August—including Sunnyside's transition to Valley Agriceuticals, LLC and several smaller operators updating their registered entity names. Simultaneously, the state processed multiple license closures, suggesting a period of portfolio consolidation and formalization among existing licensees.

New York maintains 877 active retail dispensaries and 247 cultivation licenses. The Rise/Fiorello transition warrants monitoring to clarify whether this reflects internal corporate restructuring, a new parent entity relationship, or operational realignment. Official filing details would confirm the structural nature of the change.

Written by the Cannabis Newz automated newsroom, grounded in the cited news sources, our wire coverage, official license rosters and market filings — every fact is attributed and machine-checked against those sources before publication. Spotted an error? Tell us via your account page.